期刊
BRITISH JOURNAL OF CANCER
卷 106, 期 2, 页码 405-413出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2011.462
关键词
microRNAs; prostate cancer; miR-1 and miR-133a; tumour suppressor; purine nucleoside phosphorylase (PNP)
类别
资金
- Ministry of Education, Science, Sports, and Culture [21592187, 21791530]
- Grants-in-Aid for Scientific Research [20390420, 21592187, 23592351, 21791530] Funding Source: KAKEN
BACKGROUND: Our recent analyses of miRNA expression signatures showed that miR-1 and miR-133a were significantly reduced in several types of cancer. Interestingly, miR-1 and miR-133a are located on the same chromosomal locus in the human genome. We examined the functional significance of miR-1 and miR-133a in prostate cancer (PCa) cells and identified the novel molecular targets regulated by both miR-1 and miR-133a. METHODS and RESULTS: The expression levels of miR-1 and miR-133a were significantly downregulated in PCa compared with non-PCa tissues. Restoration of miR-1 or miR-133a in PC3 and DU145 cells revealed significant inhibition of proliferation, migration, and invasion. Molecular target identification by genome-wide gene expression analysis and luciferase reporter assay showed that purine nucleoside phosphorylase (PNP) was directly regulated by both miRNAs. Silencing of the PNP gene inhibited proliferation, migration, and invasion in both PC3 and DU145 cells. Immunohistochemistry detected positive staining of PNP in PCa specimens. CONCLUSIONS: Downregulation of miR-1 and miR-133a was a frequent event in PCa and both function as tumour suppressors. The PNP is a novel target gene of both miRNAs and potentially functions as an oncogene. Therefore, identification of novel molecular networks regulated by miRNAs may provide new insights into the underlying causes of PCa oncogenesis. British Journal of Cancer (2012) 106, 405-413. doi:10.1038/bjc.2011.462 www.bjcancer.com Published online 8 November 2011 (C) 2012 Cancer Research UK
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据